AW
CANF

Avion Wealth’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Avion Wealth’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
5
– – ﹤0.01% 1461
2026
Q1 		$0 Hold
5
– – ﹤0.01% 1276
2025
Q4 		$0 Hold
5
– – ﹤0.01% 1268
2025
Q3 		$0 Hold
5
– – ﹤0.01% 1238
2025
Q2 		$0 Hold
5
– – ﹤0.01% 1210
2025
Q1 		$0 Buy
+5
New +$159 ﹤0.01% 1048
2024
Q4 		– Sell
-5
Closed – – 1031
2024
Q3 		$0 Buy
+5
New +$268 ﹤0.01% 1030

Other funds holding CANF

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avion Wealth's CANF Position: Q2 2026 in Review

Avion Wealth held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q2 2026 at 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1461.

Avion Wealth first reported a position in CANF in Q3 2024 and has held it in 7 quarters since. 8 funds tracked by Wall St. Rank hold CANF as of Q2 2026.

  • Avion Wealth held 5 shares of Can-Fite BioPharma American Depositary Shares worth $0 as of Q2 2026.
  • Avion Wealth left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q2 2026.
  • Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1461 holding.
  • Avion Wealth first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2024 and has held it in 7 quarters since.
  • 8 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.